发明名称 |
Exendin fusion proteins |
摘要 |
The invention provides fusion proteins comprising an exendin-4 fused to a transferrin (Tf) via a polypeptide linker, as well as corresponding nucleic acid molecules, vectors, host cells, and pharmaceutical compositions. The invention also provides the use of the exendin-4/Tf fusion proteins for treatment of Type Il diabetes, obesity, and to reduce body weight. |
申请公布号 |
AU2007278994(B2) |
申请公布日期 |
2013.08.15 |
申请号 |
AU20070278994 |
申请日期 |
2007.07.13 |
申请人 |
BIOREXIS PHARMACEUTICAL CORPORATION |
发明人 |
PRIOR, CHRISTOPHER PHILIP;SADEGHI, HOMAYOUN;TURNER, ANDREW JOHN;BALLANCE, DAVID JAMES |
分类号 |
C07K14/575;A61K38/22;C07K19/00;C12N15/62;C12N15/63 |
主分类号 |
C07K14/575 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|